REGULATED INFORMATION – INSIDE INFORMATION – Postponement publication half-year results 2018 and prospectus

REGULATED INFORMATION – INSIDE INFORMATION

Postponement publication half-year results 2018 and prospectus

 

Leuven, Belgium – September 27, 2018 – 18h30 – Crescent (EURONEXT: OPTI; OTC: OPNVY)

Crescent NV is fully engaged in preparing the consolidated semi-annual financial statements 2018 of the new group, taking into account the recent contribution in kind of Crescent Ventures NV and subsidiaries (this is being processed as a reverse takeover in accordance with IFRS 3). In order to have meaningful comparative figures, for the first time consolidated figures for 2017 according to IFRS are being prepared for Crescent Ventures and also the accounts of Crescent Ventures and its subsidiaries (in Belgium and the Netherlands) are audited. In addition, pro forma financial statements are drawn up for 2017 and half-year 2018 that take into account this contribution in kind.

 

Given the complexity of the composition of the required information following the new group structure, Crescent will postpone publishing both the half-year results and the detailed prospectus (equivalent information document) on the merger between Crescent Ventures NV (formerly Crescent NV) and Crescent NV ( formerly Option NV) in accordance with Article 18, paragraph 2d of the Act of 16 June 2006 on the public offer of investment instruments and the admission of investment instruments to trading on a regulated market capital increase. The half-year results will be published on October 17 before the opening of the Stock Exchange, the prospectus will follow as soon as possible thereafter.

 

Crescent also announces that the credit agreement with Belfius Bank to refinance and restructure the remaining non-financial historical debt obligations (1.5 million Euros) and to support the company with a working capital credit line of 1.5 million Euros has been signed following approval by Gigarant.

 

CONTACT

Edwin Bex

Gaston Geenslaan 14

B-3001 Leuven, België

TEL: +32 (0) 16 31 74 11

FAX: +32 (0) 16 31 74 90

E-mail: investor@option.com